CIK 0000887359
- Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- Operating
- EIN
- 943096597
- Phone
- +1 617-588-5555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-16 | GILMAN STEVEN C Director | Sale 10b5-1 | −5,833 | $41.36 | $241K | 11,000 |
| 2024-10-02 | GILMAN STEVEN C Director | Sale 10b5-1 | −5,833 | $40.35 | $235K | 11,000 |
| 2024-10-01 | SIEGAL JONATHAN Principal Accounting Officer | Sale 10b5-1 | −568 | $41.90 | $24K | 1,124 |
| 2024-09-18 | GILMAN STEVEN C Director | Sale 10b5-1 | −5,834 | $45.54 | $266K | 11,000 |
| 2024-09-12 | Colangelo Dominick President and CEO | Sale 10b5-1 | −17,500 | $43.90 | $768K | 220,937 |
| 2024-09-11 | Colangelo Dominick President and CEO | Sale 10b5-1 | −17,500 | $43.37 | $759K | 220,937 |
| 2024-09-04 | GILMAN STEVEN C Director | Sale 10b5-1 | −5,000 | $48.58 | $243K | 11,000 |
| 2024-09-03 | Hopper Jonathan Mark Chief Medical Officer | Sale 10b5-1 | −10,000 | $49.83 | $498K | 58,229 |
| 2024-08-15 | Colangelo Dominick President and CEO | Sale 10b5-1 | −17,500 | $46.24 | $809K | 220,937 |
| 2024-08-14 | Colangelo Dominick President and CEO | Sale 10b5-1 | −17,500 | $45.17 | $790K | 220,937 |
| 2024-08-07 | MCLAUGHLIN KEVIN F Director | Sale 10b5-1 | −5,000 | $45.92 | $230K | 11,900 |
| 2024-08-07 | MCLAUGHLIN KEVIN F Director | Sale 10b5-1 | −2,000 | $45.99 | $92K | 11,900 |
| 2024-07-18 | Colangelo Dominick President and CEO | Sale 10b5-1 | −17,500 | $51.40 | $900K | 220,937 |
| 2024-07-17 | Colangelo Dominick President and CEO | Sale 10b5-1 | −17,500 | $51.55 | $902K | 220,937 |
| 2024-07-16 | Flynn Sean C. Chief Legal Officer | Sale 10b5-1 | −15,000 | $52.18 | $783K | 707 |
| 2024-07-12 | Mara Joseph Anthony Jr Chief Financial Officer | Sale 10b5-1 | −5,000 | $50.00 | $250K | 14,436 |
| 2024-07-05 | SIEGAL JONATHAN Principal Accounting Officer | Sale 10b5-1 | −545 | $45.00 | $25K | 1,033 |
| 2024-06-24 | Flynn Sean C. Chief Legal Officer | Sale 10b5-1 | −1,474 | $45.84 | $68K | 487 |
| 2024-06-21 | Flynn Sean C. Chief Legal Officer | Sale 10b5-1 | −6,772 | $45.02 | $305K | 487 |
| 2024-06-20 | Flynn Sean C. Chief Legal Officer | Sale 10b5-1 | −6,754 | $45.04 | $304K | 487 |
Page 5 of 14 · 276 trades